Fireside Chat on Autolus Therapeutics' journey as a cell therapy pioneer, 12 September 2024

It was great to learn about Autolus Therapeutics' journey as a cell therapy pioneer and how their manufacturing strategies have changed over the last decade.

Fireside Chat between our CEO John W. Hadden II and Chris Williams, Chief Business Officer, Autolus.

12th September 2024 Session:
Flexibility in Action: Harnessing Adaptive Vector Platforms for Gene Therapy Manufacturing

And terrific presentations by
Cedrick Rousseaux, Innovation, Analytical, and Process Development Director, SK pharmteco
and
Su Xiao, Chief Technology Officer, Neurophth Therapeutics / 纽福斯生物科技有限公司

https://lnkd.in/dH4RP6Z6

Farzin Farzaneh, PhD, Traci Kyes, Makis Sigalas

Phacilitate Alliance for Regenerative Medicine #ate24 #advancedtherapies24 #lisbon #celltherapy #viralvectors #cellandgenetherapy